LiVeritas rolls out AI-powered integrated laboratory platform, LiLii
LiLii is a Software-as-a-Service (SaaS) platform that leverages LiVeritas’ artificial intelligence (AI) technology to simplify workflows and improve…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Jul 23
LiLii is a Software-as-a-Service (SaaS) platform that leverages LiVeritas’ artificial intelligence (AI) technology to simplify workflows and improve…
20 Jul 23
According to the trial's primary outcome measures, CoronaTcP showed a satisfactory safety profile, with no serious adverse events…
20 Jul 23
As part of the collaboration, life science companies will have access to a comprehensive de-identified dataset that specifically…
20 Jul 23
The Series B funding round was led by Bioluminescence Ventures, with participation from KdT Ventures, Piedmont Capital, and…
20 Jul 23
The oral levosimendan treatment for PH-HFpEF is covered by the issued patent (US Patent No. 11,701,355), which grants…
20 Jul 23
As part of the research agreement, Pfizer will support Riparian’s efforts to discover further drug targets leading to…
20 Jul 23
The Company intends to use funds awarded by the Bill & Melinda Gates Foundation toward completion of tuberculosis…
20 Jul 23
Under the terms of the agreement, Biotheus will grant BioNTech worldwide, exclusive options to a preclinical-stage bispecific antibody…
20 Jul 23
On 5 May 2023, France reported an increase in cases of severe neonatal sepsis associated with Enterovirus (Echovirus-11…
19 Jul 23
Safety, sustainability and regulation are three of the biggest challenges facing the food & beverage ingredient industry in…